Alkermes
ALKS
#2756
Rank
NZ$10.58 B
Marketcap
NZ$63.48
Share price
-0.77%
Change (1 day)
19.72%
Change (1 year)

P/E ratio for Alkermes (ALKS)

P/E ratio as of May 2026 (TTM): 40.0

According to Alkermes's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 39.9892. At the end of 2025 the company had a P/E ratio of 19.0.

P/E ratio history for Alkermes from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
202519.047.59%
202412.9-0.04%
202312.9-147.4%
2022-27.2-64.89%
2021-77.5172.37%
2020-28.575.82%
2019-16.2
2017-53.130.98%
2016-40.6-22.32%
2015-52.2-82.16%
2014-293

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
26.2-34.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
21.2-46.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
19.3-51.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
17.0-57.46%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
16.1-59.74%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
26.5-33.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-6.56-116.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-0.0676-100.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
24.8-37.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.